Mosis G, Gutierrez LP, Dieleman J, Castellsague J, Sturkenboom M. No changes in channeling of COX-2 Specific inhibitors in the first three years after marketing. Poster presented at the ISoP Annual Conference ‘Pharmacovigilance in Clinical Practice’; October 2003. Marrakech, Morocco. [abstract] Pharmacoepidemiol Drug Saf. 2003 Oct; 12(S2):S243.